Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

December 27, 2019 00:23:35
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?
Critical Care Perspectives in Emergency Medicine
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

Dec 27 2019 | 00:23:35

/

Show Notes

Up to one-third of patients with status epilepticus will not respond to benzodiazepines.  Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied.  The longer seizures persist, the worse patients do.  In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

October 04, 2019 00:29:51
Episode Cover

Extubating in the ED

Given the development of ED-ICUs and the ever increasing boarding of critically ill patients in the ED, extubation in the ED has become a...

Listen

Episode 0

April 27, 2020 00:22:04
Episode Cover

Vasopressors & The Older Patient - The 65 Trial

Current guidelines for many critical illnesses recommend targeting a MAP of 65 mm Hg, with consideration of higher MAPs in older patients with chronic...

Listen

Episode 0

May 03, 2018 00:44:19
Episode Cover

A Clean Kill? Ventilating the Asthmatic Patient

Mechanically ventilating the patient with a severe asthma exacerbation is fraught with peril.  Incorrect settings for tidal volume, respiratory rate, pressure triggers, or inspiratory...

Listen